{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:42:59Z","timestamp":1788982979183,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1564,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A13044"],"award-info":[{"award-number":["A13044"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["4054"],"award-info":[{"award-number":["4054"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["250170"],"award-info":[{"award-number":["250170"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["098439\/Z\/12\/2"],"award-info":[{"award-number":["098439\/Z\/12\/2"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["A13044"],"award-info":[{"award-number":["A13044"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["4054"],"award-info":[{"award-number":["4054"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["250170"],"award-info":[{"award-number":["250170"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["098439\/Z\/12\/2"],"award-info":[{"award-number":["098439\/Z\/12\/2"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["A13044"],"award-info":[{"award-number":["A13044"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["4054"],"award-info":[{"award-number":["4054"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["250170"],"award-info":[{"award-number":["250170"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["098439\/Z\/12\/2"],"award-info":[{"award-number":["098439\/Z\/12\/2"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["A13044"],"award-info":[{"award-number":["A13044"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["4054"],"award-info":[{"award-number":["4054"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["250170"],"award-info":[{"award-number":["250170"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["098439\/Z\/12\/2"],"award-info":[{"award-number":["098439\/Z\/12\/2"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ajpath.2015.05.018","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T15:06:59Z","timestamp":1437923219000},"page":"2354-2363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-\u03baB Regulation"],"prefix":"10.1016","volume":"185","author":[{"given":"Stephen A.","family":"Watt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J.","family":"Purdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline Y.","family":"den Breems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Dimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T.","family":"Arron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasbani H.S.","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Proby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.05.018_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajpath.2015.05.018_bib3","first-page":"268","article-title":"Prognostic factors for metastasis in squamous cell carcinoma of the skin","volume":"28","author":"Cherpelis","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ajpath.2015.05.018_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","article-title":"Temporal dissection of tumorigenesis in primary cancers","volume":"1","author":"Durinck","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2015.05.018_bib5","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib6","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.2013.276","article-title":"Mutational landscape of basal cell carcinomas by whole-exome sequencing","volume":"134","author":"Jayaraman","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib8","doi-asserted-by":"crossref","first-page":"a013623","DOI":"10.1101\/cshperspect.a013623","article-title":"Modeling cutaneous squamous carcinoma development in the mouse","volume":"4","author":"Huang","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajpath.2015.05.018_bib9","first-page":"3468","article-title":"Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in\u00a0vivo","volume":"59","author":"Duffey","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib10","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1158\/0008-5472.CAN-04-0852","article-title":"Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma","volume":"64","author":"Loercher","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01283","article-title":"NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia","volume":"421","author":"Dajee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.05.018_bib12","first-page":"3299","article-title":"Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel\/nuclear factor-kappaB signaling","volume":"59","author":"van Hogerlinden","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-kappaB, the first quarter-century: remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2015.05.018_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0092-8674(00)80406-7","article-title":"The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation","volume":"91","author":"Zandi","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.05.018_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.05.018_bib16","doi-asserted-by":"crossref","first-page":"re13","DOI":"10.1126\/stke.3572006re13","article-title":"Regulation and function of IKK and IKK-related kinases","volume":"2006","author":"Hacker","year":"2006","journal-title":"Sci STKE"},{"key":"10.1016\/j.ajpath.2015.05.018_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-065X.2012.01109.x","article-title":"Role of NF-kappaB in epithelial biology","volume":"246","author":"Pasparakis","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajpath.2015.05.018_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1083\/jcb.149.5.999","article-title":"It's got you covered. NF-kappaB in the epidermis","volume":"149","author":"Kaufman","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.95.5.2307","article-title":"Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB","volume":"95","author":"Seitz","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2015.05.018_bib20","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1101\/gad.9.22.2736","article-title":"Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice","volume":"9","author":"Beg","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2015.05.018_bib21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nature00820","article-title":"TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2","volume":"417","author":"Pasparakis","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2015.05.018_bib22","doi-asserted-by":"crossref","first-page":"19610","DOI":"10.1074\/jbc.M603384200","article-title":"TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis","volume":"281","author":"Omori","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.05.018_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2015.05.018_bib25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2015.05.018_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajpath.2015.05.018_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2012.01110.x","article-title":"Regulation of NF-kappaB by the CARD proteins","volume":"246","author":"Jiang","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajpath.2015.05.018_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/cr.2010.182","article-title":"NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins","volume":"21","author":"Blonska","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib29","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/1078-0432.CCR-10-1859","article-title":"A20, ABIN-1\/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma","volume":"17","author":"Dong","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/MCB.00850-12","article-title":"A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival","volume":"33","author":"Chan","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.05.018_bib32","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1084\/jem.20120831","article-title":"Congenital B cell lymphocytosis explained by novel germline CARD11 mutations","volume":"209","author":"Snow","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2015.05.018_bib33","article-title":"The catalogue of somatic mutations in cancer (COSMIC)","volume":"Chapter 10","author":"Forbes","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.ajpath.2015.05.018_bib34","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/onc.2011.180","article-title":"Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma","volume":"30","author":"Watt","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2015.05.018_bib35","doi-asserted-by":"crossref","first-page":"970","DOI":"10.15252\/emmm.201303541","article-title":"Epidermal p65\/NF-kappaB signalling is essential for skin carcinogenesis","volume":"6","author":"Kim","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2015.05.018_bib36","doi-asserted-by":"crossref","first-page":"e71887","DOI":"10.1371\/journal.pone.0071887","article-title":"A role for NF-kappaB activity in skin hyperplasia and the development of keratoacanthomata in mice","volume":"8","author":"Poligone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.05.018_bib37","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1128\/MCB.00418-08","article-title":"The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association","volume":"28","author":"McCully","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/MCB.24.1.164-171.2003","article-title":"CD3\/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1","volume":"24","author":"Wang","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.1107107","article-title":"PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation","volume":"308","author":"Lee","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2015.05.018_bib40","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1074\/jbc.M010512200","article-title":"CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B","volume":"276","author":"Bertin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.05.018_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.jid.5700157","article-title":"Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia","volume":"126","author":"Haider","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jcp.24543","article-title":"The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders","volume":"229","author":"Scudiero","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni830","article-title":"CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation","volume":"3","author":"Gaide","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2015.05.018_bib44","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/0008-5472.CAN-05-4158","article-title":"Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(03)00141-9","article-title":"Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis","volume":"18","author":"Jun","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2015.05.018_bib46","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.05.018_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ccr.2012.11.011","article-title":"A new \u201cbrew\u201d of MALT1 inhibitors","volume":"22","author":"Young","year":"2012","journal-title":"Cancer Cell"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401500365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401500365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:45:23Z","timestamp":1617234323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401500365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S000294401500365X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.018","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-\u03baB Regulation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}